Effect of beraprost on pulmonary hypertension due to left ventricular systolic dysfunction

Beraprost is used to treat peripheral chronic arterial occlusive disease. However, the efficacy and safety of beraprost in patients with pulmonary hypertension (PH) due to left ventricular systolic dysfunction (PH-HFrEF) remains unknown. The primary objective of this study was to determine the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Zhu, Xinyi, Zhao, Liang-Ping, Wang, Maosong, Liu, Xiang, Chen, Yuqi, Chen, JianChang, Xu, WeiTing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494404/
https://www.ncbi.nlm.nih.gov/pubmed/31008926
http://dx.doi.org/10.1097/MD.0000000000014965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494404/
https://www.ncbi.nlm.nih.gov/pubmed/31008926
http://dx.doi.org/10.1097/MD.0000000000014965

Ejemplares similares